We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-0.97%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.55B
AUM Growth
+$133M
Cap. Flow
+$228M
Cap. Flow %
6.44%
Top 10 Hldgs %
31.71%
Holding
123
New
40
Increased
24
Reduced
23
Closed
30

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$71.8M
2
ABBV icon
AbbVie
ABBV
+$63.8M
3
CI icon
Cigna
CI
+$62.3M
4
PBYI icon
Puma Biotechnology
PBYI
+$49.5M
5
UNH icon
UnitedHealth
UNH
+$44.3M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$99.2M
2
META icon
Meta Platforms (Facebook)
META
+$73.1M
3
BAX icon
Baxter International
BAX
+$70M
4
NOW icon
ServiceNow
NOW
+$67.7M
5
V icon
Visa
V
+$65.5M

Sector Composition

Rank Sector Weight
1 Healthcare 40.7%
2 Technology 6.07%
3 Energy 6.01%
4 Industrials 3.89%
5 Communication Services 3.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLV icon
1
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$41.5B
$187M 5.27%
+2,713,300
New +$188M
BIIB icon
2
Biogen
BIIB
$29.5B
$166M 4.68%
585,710
-5,141
-0.9% -$1.52M
DTD icon
3
CALL
WisdomTree US Total Dividend Fund
DTD
$1.64B
$135M 3.81%
+5,461,800
New +$215M
CI icon
4
Cigna
CI
$76.8B
$102M 2.88%
764,809
+476,402
+165% +$62.3M
JAZZ icon
5
Jazz Pharmaceuticals
JAZZ
$15.3B
$102M 2.87%
933,123
-228,179
-20% -$25.4M
MDCO
6
DELISTED
Medicines Co
MDCO
$92.2M 2.6%
2,717,441
+969,243
+55% +$34.4M
BMRN icon
7
BioMarin Pharmaceuticals
BMRN
$11.4B
$87.6M 2.47%
1,057,559
+334,821
+46% +$28.8M
RRC icon
8
Range Resources
RRC
$8.89B
$86.2M 2.43%
2,509,143
+1,097,165
+78% +$39.3M
UNH icon
9
UnitedHealth
UNH
$396B
$84.4M 2.38%
527,565
+296,675
+128% +$44.3M
UNP icon
10
Union Pacific
UNP
$176B
$82.4M 2.32%
794,550
-232,431
-23% -$22.9M
ZAYO
11
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$81.8M 2.31%
2,490,551
+829,685
+50% +$27.2M
EW icon
12
Edwards Lifesciences
EW
$48.9B
$80.7M 2.27%
2,582,169
-121,620
-4% -$3.94M
HAIN icon
13
Hain Celestial
HAIN
$53.2M
$79.3M 2.23%
2,030,602
+1,071,573
+112% +$40.1M
ELV icon
14
Elevance Health
ELV
$82.9B
$77.1M 2.17%
+536,457
New +$71.8M
VTRS icon
15
PUT
Viatris
VTRS
$20.5B
$74.9M 2.11%
+1,964,500
New +$73M
ABBV icon
16
AbbVie
ABBV
$452B
$73.4M 2.07%
1,171,367
+1,045,383
+830% +$63.8M
HUM icon
17
Humana
HUM
$47.8B
$71.8M 2.02%
351,791
+94,479
+37% +$18M
ILMN icon
18
CALL
Illumina
ILMN
$27.9B
$71.3M 2.01%
+572,802
New +$77.2M
CRM icon
19
Salesforce
CRM
$139B
$63M 1.78%
920,244
+567,346
+161% +$41.2M
ALDR
20
DELISTED
Alder Biopharmaceuticals
ALDR
$60.6M 1.71%
2,913,951
+906,287
+45% +$23.6M
CLVS
21
DELISTED
Clovis Oncology, Inc.
CLVS
$56.8M 1.6%
1,278,855
+510,765
+66% +$18M
AERI
22
DELISTED
Aerie Pharmaceuticals
AERI
$54.3M 1.53%
1,435,755
-530,662
-27% -$20.1M
WBA
23
DELISTED
Walgreens Boots Alliance
WBA
$53.4M 1.51%
645,665
-440,760
-41% -$36.4M
SLCA
24
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$48.6M 1.37%
856,871
+435,023
+103% +$21.5M
KITE
25
DELISTED
Kite Pharma, Inc.
KITE
$44.7M 1.26%
997,464
+496,378
+99% +$24.3M
1
2 3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
AWP
Abacus Wealth Partners Santa Monica, California $1.1B AUM 14.74% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

PFM Health Sciences's Q4 2016 Portfolio in Review

As of Q4 2016, PFM Health Sciences held 123 positions worth $3.55B, up 3.9% from $3.42B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

PFM Health Sciences deployed $228M of net new capital in Q4 2016, opening 40 new positions and adding to 24 existing holdings. Its largest new stake was Elevance Health: 536,457 shares worth $77.1M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 37% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $73.1M trimmed.

  • PFM Health Sciences's largest Q4 2016 buy was Elevance Health: 536,457 shares worth $77.1M.
  • PFM Health Sciences added most to AbbVie in Q4 2016, an estimated $63.8M increase.
  • PFM Health Sciences's biggest Q4 2016 reduction was Meta Platforms (Facebook), cutting an estimated $73.1M.
  • PFM Health Sciences fully exited Apple in Q4 2016, selling an estimated $99.2M.
  • PFM Health Sciences's ten largest holdings make up 32% of its $3.55B portfolio in Q4 2016.
  • PFM Health Sciences opened 40 new positions and closed 30 in Q4 2016.
  • PFM Health Sciences's portfolio value rose 3.9% quarter-over-quarter to $3.55B.

Based on PFM Health Sciences's 13F filing for Q4 2016, filed 14 Feb 2017.